Newsroom | Top Stories | Abbott U.S.
WEBJan 19, 2024 · Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
Abbott MediaRoom - Press Releases
WEBJul 24, 2024 · Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside. Mar 27, 2024.
Abbott Receives U.S. FDA Clearance for Two New Over-the …
WEBABBOTT PARK, Ill., June 10, 2024 / PRNewswire / -- Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo™ and Libre Rio™, which are based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring technology 1, now used b...
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of …
WEBMar 31, 2024 · Excluding COVID-19 testing-related sales, global Core Laboratory Diagnostics sales increased 2.2 percent on a reported basis and 6.2 percent on an organic basis, led by continued strong adoption of Abbott's Alinity ® family of diagnostics systems and testing portfolios.
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, …
WEBApr 17, 2024 · ABT. Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance. Wednesday, Abbott Laboratories (NYSE: ABT) reported first-quarter sales of $9.96 billion, up...
Abbott’s Q4 Earnings Sustain Momentum Into 2024
WEBJan 24, 2024 · Sales for the fourth quarter of 2023 reached $10.2 billion, an 11.0% organic increase, excluding COVID-19 testing-related revenue, driven by Medical Devices (up 15.4% organic; 17.5% reported) and Nutrition (up 13.9% organic; 12.2% reported).
Abbott Q4 Earnings: Continued Resiliency | Abbott Newsroom
WEBJan 25, 2023 · Abbott issued full-year guidance for 2023 adjusted diluted EPS from continuing operations of $4.30 to $4.50. 3 These are the key fourth-quarter highlights: Sales of FreeStyle Libre systems exceeded $1 billion with U.S. sales growing more than 40%.
Abbott Laboratories (ABT) Gets a Buy from Wells Fargo
WEB2 days ago · The word on The Street in general, suggests a Strong Buy analyst consensus rating for Abbott Laboratories with a $127.08 average price target, a 7.58% upside from current levels.
After baby formula problems, Abbott Laboratories under DOJ ... - NBC News
WEBJan 21, 2023 · Abbott Laboratories is under investigation by the U.S. Department of Justice, the company confirmed Friday, almost a year after it shut down a Michigan baby-formula plant after illnesses were...
Abbott Laboratories (ABT) Latest Stock News & Headlines
WEBGet the latest Abbott Laboratories (ABT) stock news and headlines to help you in your trading and investing decisions.